Ketamine News and Research

RSS

Repeated infusions of ketamine for migraines or pain not linked to increased adverse events

Repeated infusions of ketamine treatments for migraines or pain was not associated with increased risk for hepatotoxicity or psychomimetic adverse drug events (ADEs), according to research from Thomas Jefferson University Hospital in Philadelphia, PA, and the University of Virginia at Charlottesville.

6 Nov 2019

One in three patients may experience side effects from ketamine infusions for pain management

As the opioid epidemic continues to devastate the United States, ketamine use has grown as a pain management alternative, yet more than one in three patients may experience side effects such as hallucinations and visual disturbances, suggests new research presented at the ANESTHESIOLOGY 2019 annual meeting.

21 Oct 2019

Colorectal surgery patients in ERAS program report less pain, use fewer opioids

Colorectal surgery patients who were a part of an enhanced recovery after surgery program had less pain, while using nearly half as many opioids, according to research being presented at the ANESTHESIOLOGY 2019 annual meeting.

20 Oct 2019

New technique for police to quickly and safely test drug evidence

Scientists have demonstrated a way for police to quickly and safely test whether a baggie or other package contains illegal drugs without having to handle any suspicious contents directly.

17 Sep 2019

Study reveals link between popular pain medication and greater risk of hypoglycemia

Since its approval in 1995, the opioid tramadol (marketed as ConZip and Ultram) has become a widely prescribed remedy for osteoarthritis and other painful indications, in part because it presents a lesser risk for some side effects and has a lower abuse potential when compared to other opioids.

28 Aug 2019

Evidence shows ketamine is not opioid and can treat depression easily

Ketamine’s reputation as an antidepressant is restored; it’s not an opioid.

From Johns Hopkins Medicine 1 Aug 2019

Measuring pupil dilation and heart rate using AI could enable earlier diagnosis of autism

Autism and other neurodevelopmental disorders often aren't diagnosed until a child is a few years of age, when behavioral interventions and speech/occupational therapy become less effective.

24 Jul 2019

FDA overlooked red flags in drugmaker’s testing of new depression medicine

Ketamine is a darling of combat medics and clubgoers, an anesthetic that can quiet your pain without suppressing breathing and a hallucinogenic that can get you high with little risk of a fatal overdose.

11 Jun 2019

Chemical changes in the brain may be associated with unexplained motor symptoms

A new study finds that people who have movement problems, symptoms that cannot be explained by an underlying disease, may have chemical changes in specific areas of the brain.

6 Jun 2019

Microextraction gets an eco-friendly makeover in new cannabis study

Researchers have successfully demonstrated that IT-SPME coupled to nano-LC is an adequate analytical method for the characterization of cannabis traces.

15 May 2019

New insight into fast-growing retail and medicinal cannabis industry

Edison Group, the leading investment and research advisory company, has published its sector report analyzing the growing retail and medicinal cannabis industry.

3 May 2019

Researchers use nitrous oxide to unravel rapid function of antidepressant mechanisms

Ketamine is commonly used in emergency medicine as an anesthetic drug. Later it was discovered to have rapid-acting antidepressant effects, but the mechanisms by which ketamine alleviates depression are still unknown.

29 Apr 2019

Researchers identify ketamine-induced neural changes responsible for remission of depression

Researchers have identified ketamine-induced brain-related changes that are responsible for maintaining the remission of behaviors related to depression in mice -- findings that may help researchers develop interventions that promote lasting remission of depression in humans.

12 Apr 2019

Workings of ketamine in depressive illness decoded

Researchers have now found the exact mechanism of how the drug works in the brains of individuals with depression and can keep the symptoms down for more than a week.

12 Apr 2019

Research uncovers crucial receptor involved in response to fast-acting antidepressants

Effective treatment of clinical depression remains a major mental health issue, with roughly 30 percent of patients who do not respond to any of the available treatments.

29 Mar 2019

Fingermark imaging for identification of drugs

In a paper to be published in the forthcoming issue in NANO, researchers from Zhejiang have uncovered a novel method of using nanocarrier-based biological fluorescent probes for detecting amphetamine and ketamine in latent fingermark, in a bid to combat drug abuse.

15 Mar 2019

Mild ecstasy use linked to greater empathy, PTSD research

MDMA or ecstasy is a popular rave drug used in party circuits to generate euphoria and become more sociable. Researchers from the University of Exeter and University College London have also been studying this recreation drug of abuse for its possible medicinal use in post traumatic stress disorder (PTSD) and alcohol de-addiction.

11 Feb 2019